Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma
Clinical trial NCT07243626 · RECRUITING
Trial details
- NCT number
- NCT07243626
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2026-12-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.